Anthony Chow, UK

 Anthony is CEO of Mann Bioinvest, part of Jim Mellon’s family office focus on life sciences where he is part of the direct investments team.  Anthony is a founding member of Juvenescence Limited, and played a key role in the investments in Insilico Medicine, the investment in and restructuring of Plethora Solutions (now owned by Regent Pacific Group), The Diabetic Boot Company, SalvaRx Group and Intensity Therapeutics.
Anthony holds a Bachelor of Economics Degree from The University of Sydney and a Post Graduate Diploma in Accounting from Macquarie University. He was awarded the CFA designation in 2010.